In this context, we previously demonstrated that the P2X7 receptor antagonist, brilliant blue G, reduces neuroinflammation and ameliorates some of the pathological features of ALS in the SOD1-G93A mouse model. The gene discussed is P2RX7; the disease is amyotrophic lateral sclerosis.